Skip to Content

Posts tagged with "Academia (vs. Industry)"

  • Academia (vs. Industry)

    Roche Prevails Over Stanford

    The Supreme Court has ruled on the Roche – Stanford case that I blogged about here. In short, the dispute centered on the Bayh-Dole act (on commercializing academic research) and sought to clarify under what circumstances university collaborators signed over the rights to their discoveries. (That makes the case sound quite calm and removed fr… Read More
  • Academia (vs. Industry)

    Maybe It Really Is That Hard?

    Here’s an interesting note from the Wall Street Journal‘s Health Blog. I can’t summarize it any better than they have: “When former NIH head Elias Zerhouni ran the $30 billion federal research institute, he pushed for so-called translational research in which findings from basic lab research would be used to develop medicine… Read More
  • "Me Too" Drugs

    Translation Needed

    The “Opinionator” blog at the New York Times is trying here, but there’s something not quite right. David Bornstein, in fact, gets off on the wrong foot entirely with this opening: Consider two numbers: 800,000 and 21. The first is the number of medical research papers that were published in 2008. The second is the… Read More
  • Academia (vs. Industry)

    The PhD Problem: A Global Perspective

    Nature News has a big article on the “Too Many PhDs” problem, which we’ve discussed several times around here: In some countries, including the United States and Japan, people who have trained at great length and expense to be researchers confront a dwindling number of academic jobs, and an industrial sector unable to take up… Read More
  • Academia (vs. Industry)

    Nothing Personal

    There’s an interesting follow-up over at SciBX to Bruce Booth’s piece on the reproducibility of academic research. Booth, in his position as a venture capital purse-string holder, advocated caution and careful verification of exciting academic discoveries before starting the company-formation process. The SciBX folks followed up with hi… Read More
  • Academia (vs. Industry)

    Roche and Stanford: Academia v. Industry?

    One morning back in 1989, a guy from Stanford visited the biotech company Cetus and signed a few forms. That action has gradually become the central issue in a nasty patent dispute that’s dragged on for years. Roche (who bought Cetus in 1991) and Stanford have been fighting it out through the judicial system, and… Read More
  • Academia (vs. Industry)

    What If Those Wonderful Results Are Wrong?

    Venture-capital guy Bruce Booth has a provocative post, based on experience, about how reproducible those papers are that make you say “Someone should try to start a company around that stuff”. The unspoken rule is that at least 50% of the studies published even in top tier academic journals – Science, Nature, Cell, PNAS, etc…… Read More
  • Academia (vs. Industry)

    The NIH Goes For the Gusto

    Here’s an interesting funding opportunity from NIH: Recent advances in neuroscience offer unprecedented opportunities to discover new treatments for nervous system disorders. However, most promising compounds identified through basic research are not sufficiently drug-like for human testing. Before a new chemical entity can be tested in a cli… Read More
  • Academia (vs. Industry)

    More On the Postdoc Situation

    Here’s a good article (“Academia Faces PhD Overload”) via Genomeweb on the academic post-doc situation in the sciences, which we were last discussing here. (Thanks to Jonathan Gitlin on Twitter for noting it). That was in response to a Nature News piece calling for more “permanent postdoc” positions, which I doubted wo… Read More
  • Academia (vs. Industry)

    A Postdoc’s Lament

    Here’s a call to make something different out of the postdoctoral position. Says Jennifer Rohn in Nature News: “. . .we should professionalize the postdoc role and turn it into a career rather than a scientific stepping stone. Consider the scientific community as an ecosystem, and it is easy to see why postdocs need another… Read More